Biomaterial Database

Uterine rupture during induction of labor at term with intravaginal misoprostol. 1997

B B Bennett

Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, USA.

BACKGROUND Misoprostol (prostaglandin E1) compares favorably with dinoprostone (prostaglandin E2) and oxytocin for labor induction at term. Excessive uterine activity has been reported using high-dose regimens, but no negative effect on outcomes has been observed. METHODS Labor was induced in a 34-year-old multipara at 39 weeks' gestation using intravaginal misoprostol tablets. Five hours after administration of the second 25-microgram dose, fetal bradycardia prompted emergency cesarean delivery. Hysterectomy and left salpingo-oophorectomy were necessary to control bleeding from a 15-cm posterior uterine wall rupture. CONCLUSIONS Misoprostol can cause excessive uterine activity and uterine rupture.

UI	MeSH Term	Description	Entries
D007044	Hysterectomy	Excision of the uterus.	Hysterectomies
D007751	Labor, Induced	Artificially induced UTERINE CONTRACTION.	Induced Labor,Induction of Labor,Labor Induced,Labor Induction,Induced, Labor,Induction, Labor,Inductions, Labor,Labor Inductions
D010052	Ovariectomy	The surgical removal of one or both ovaries.	Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D010120	Oxytocics	Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)	Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D011247	Pregnancy	The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.	Gestation,Pregnancies
D011263	Pregnancy Trimester, Third	The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation.	Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D002585	Cesarean Section	Extraction of the FETUS by means of abdominal HYSTEROTOMY.	Abdominal Delivery,Delivery, Abdominal,C-Section (OB),Caesarean Section,Postcesarean Section,Abdominal Deliveries,C Section (OB),C-Sections (OB),Caesarean Sections,Cesarean Sections,Deliveries, Abdominal
D004630	Emergencies	Situations or conditions requiring immediate intervention to avoid serious adverse results.	Emergency
D005260	Female		Females
D005316	Fetal Distress	A nonreassuring fetal status (NRFS) indicating that the FETUS is compromised (American College of Obstetricians and Gynecologists 1988). It can be identified by sub-optimal values in FETAL HEART RATE; oxygenation of FETAL BLOOD; and other parameters.	Nonreassuring Fetal Status,Fetal Status, Nonreassuring

Related Publications

B B Bennett

Low dose intravaginal misoprostol for induction of labor at term.

July 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,

B B Bennett

Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study.

October 1997, Obstetrics and gynecology,

B B Bennett

Labor induction with intravaginal misoprostol in term premature rupture of membranes: a randomized study.

June 1997, Obstetrics and gynecology,

B B Bennett

Uterine rupture in a multiparous woman during labor induction with oral misoprostol.

January 2000, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,

B B Bennett

Induction of labor with intravaginal administration of misoprostol.

March 1998, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,

B B Bennett

Pregnancy outcome following induction of labor with intravaginal misoprostol for decreased fetal movements at term.

October 2011, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,

B B Bennett

Uterine rupture associated with use of misoprostol for induction of labor.

January 2002, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,

B B Bennett

Induction of labor with intravaginal misoprostol versus intracervical dinoprostone.

January 1997, Archives of gynecology and obstetrics,

B B Bennett

Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal misoprostol.

June 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,

B B Bennett

Orally administered misoprostol for induction of labor with prelabor rupture of membranes at term.

January 2014, Journal of midwifery & women's health,